tiprankstipranks
Trending News
More News >
Gain Therapeutics (GANX)
NASDAQ:GANX
US Market

Gain Therapeutics (GANX) Cash flow

Compare
402 Followers

Gain Therapeutics Cash Flow

GANX's free cash flow for Q3 2025 was $-4.93M. For the 2025 fiscal year, GANX's free cash flow was decreased by $-15.09K and operating cash flow was $-4.93M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -18.87M$ -18.87M$ -14.69M$ -12.37M$ -3.24M
Investing Cash Flow
$ 4.98M$ 10.22M$ -14.77M$ -94.21K$ -20.83K
Financing Cash Flow
$ 13.01M$ 12.64M$ -78.77K$ 41.77M$ 10.49M
End Cash Position
$ 10.42M$ 11.83M$ 7.34M$ 36.91M$ 7.50M
Free Cash Flow
$ -18.90M$ -18.88M$ -14.81M$ -12.46M$ -3.26M
Currency in USD

Gain Therapeutics Cash Flow